Feature|Articles|September 17, 2026

How PBMs are supporting women’s health, Part 1

Women face more gaps in healthcare than men, from missed screenings, undertreatment and biased coverage. PBMs are launching programs to address some of the gaps.

Women are less likely than men to be screened for many conditions, including cardiovascular diseases, gynecological conditions, maternal health and mental health. These gaps come from a lack of adequate access to healthcare, according to a report published in May 2026 that was conducted by McKinsey Health Institute and the World Economic Forum (WEF).

Related to this article

red hands, White person, with blue gloved hand and a stethoscope in corner of image | ©Rochu_2008

October 31st, 2026

How common is atopic dermatitis in the US? Not nearly as common as other research has shown, according to this study

Findings from an analysis of IQVIA claims data show a prevalence rate that is five times lower than previous reports. Some of the discrepancy could be chalked up to the difference between using claims data instead of self-reporting by survey respondents.

October 30th, 2026

Team-based reassessment helps most patients with borderline resectable lung cancer reach surgery after immunotherapy

In the MDT-BRIDGE trial, 92% of patients with stage II-III lung cancer reached surgery or chemoradiation after a midtreatment tumor board review.

October 30th, 2026

Fewer than half of newly diagnosed children with type 1 diabetes get autoantibody testing

Epic Research finds over half of children with type 1 diabetes miss autoantibody testing, risking misdiagnosis and limiting early treatment options like Tzield.

October 30th, 2026

Liver MRI marker tied to lower quality of life in MASH, trial finds

Higher MRI-measured liver disease activity was linked to lower quality of life and more anxiety and activity problems in 802 adults with suspected MASLD/MASH in Europe.

October 30th, 2026

Lower fitness tied to persistent fatty liver disease in teen boys with obesity

Teen boys with obesity and lower baseline fitness were less likely to see MASLD resolve during a lifestyle program, a Belgian study found.

October 30th, 2026

Medicaid can't opt out of gene therapies, so planning matters more, says Katelyn Meyer, Pharm.D. | AMCP Nexus 2026

MassHealth's Katelyn Meyer, Pharm.D., says mandatory coverage, young patients and an unpredictable FDA make planning for new specialty drugs a challenge.

October 30th, 2026

What employers should demand from a truly transparent PBM

A truly transparent PBM arrangement starts with full disclosure of direct and indirect compensation.

October 29th, 2026

Labor Department rule ushers in a new era of PBM transparency for self-insured employers

The rule requires pharmacy benefit managers to disclose rebates and discounts, money made from spread pricing and incentives for formulary placement.